News

ADVANCE-ID is pleased to share a significant milestone in the Phase 2b RIV-CARE clinical trial, following BioVersys’ announcement on 29 October 2026 of the first patient first visit in the study. RIV-CARE is an …
October 29, 2026
ADVANCE-ID, in collaboration with the World Health Organization (WHO), successfully organised the ADVANCE-ID Clinical Trial Workshop 2026 from 31 August to 2 September 2026 in Singapore. The two-and-a-half-day workshop brought together researchers and international …
September 2, 2026

Recruitment Updates

67

Active sites

21

Countries

13448

Patients enrolled

4440

VAP/HAP

9676

BSI

Our study sites

Logo-Lockup

Copyright © ADVANCE-ID. All rights reserved.

ADVANCE-ID
Saw Swee Hock School of Public Health
National University of Singapore

Tahir Foundation Building
National University of Singapore
12 Science Drive 2, #10-01, Singapore 117549
+65 6516 4988